Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report. [electronic resource]
Producer: 19821203Description: 1713-7 p. digitalISSN:- 0361-5960
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- therapeutic use
- Female
- Gastrointestinal Neoplasms -- drug therapy
- Humans
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Myeloproliferative Disorders -- chemically induced
- Prognosis
- Random Allocation
- Razoxane -- therapeutic use
- Triazines -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.